AMCP eLearning Days 5 days. 10+ webinars. Endless learning opportunities. Register Now Close

Most Popular

Implications for Managed Care Pharmacy from the 2021 and 2022 Med...

AMCP webinar that reviewed the provisions contained in the proposed Contract Year 2021 and 2022 Medicare Advantage and Part D rule that was released by the Centers for Medicare and Medicaid Services (CMS) on February 5, 2020.


Market Insights - Future Treatments in Migraine and Cluster Heada...

AMCP webinar that reviewed a summary of discussions from this summit.


Rutledge v. The Pharmaceutical Care Management Association: Impac...

AMCP webinar that examined the impact of the Rutledge v. The Pharmaceutical Care Management Association (PCMA) case on managed care pharmacy.


Digital Therapeutics: What Are They and Where Do They Fit in Phar...

AMCP webinar that reviewed proceedings from this Partnership Forum.


Drug Utilization Review

Drug utilization review (DUR) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication. DUR encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met.


Career Transitions: From Post-grad to Employee

AMCP webinar that offered career advice for those transitioning from their post-grad experience (residency/fellowship) into the workforce.


What is Managed Care Pharmacy?

AMCP webinar that gave a general overview of managed care pharmacy.


Disease Management

Disease management is the concept of reducing health care costs and improving quality of life for individuals with chronic conditions by preventing or minimizing the effects of the disease through integrated care. Disease management programs are designed to improve the health of persons with chronic conditions and reduce associated costs from avoidable complications by identifying and treating chronic conditions more quickly and more effectively, thus slowing the progression of those diseases.


Medication Errors

Medication errors are among the most common medical errors, harming at least 1.5 million people every year. The extra medical costs of treating drug-related injuries occurring in hospitals alone are at least to $3.5 billion a year, and this estimate does not take into account lost wages and productivity or additional health care costs.